Clinicopathological evaluation of the programmed cell death 1 (PD1)/programmed cell death-ligand 1 (PD-L1) axis in posttransplant lymphoproliferative disorders: Association with Epstein–Barr virus, PD-L1 copy number alterations, and outcome
Histopathology Oct 11, 2019
Veloza L, Teixido C, Castrejon N, et al. - Programmed cell death 1 (PD1)/programmed cell death-ligand 1 (PD-L1) expression was investigated in 50 people with posttransplant lymphoproliferative disorders, and the relationships with PD-L1 copy number alterations (CNAs), Epstein–Barr virus (EBV), clinicopathological characteristics and outcome were assessed. In posttransplant lymphoproliferative disorders, the PD1/PD-L1 axis was deregulated along with many PD-L1 expression and PD1 negativity. PD-L1 expression was correlated with EBV latency II or III and PD-L1 CNAs and apparently highlighted a proinflammatory tumor microenvironment. Moreover, of EBV status and PD-L1 expression, the combined analysis could aid to recognize profoundly immunosuppressed individuals who could profit from immune reconstitution strategies.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries